These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 20664331

  • 1. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM, Boden WE, Frye RL.
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM, Addo T.
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [Abstract] [Full Text] [Related]

  • 3. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK, BARI 2D Study Group.
    J Am Coll Cardiol; 2013 Apr 30; 61(17):1767-76. PubMed ID: 23500245
    [Abstract] [Full Text] [Related]

  • 4. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.
    Circulation; 2009 Dec 22; 120(25):2529-40. PubMed ID: 19920001
    [Abstract] [Full Text] [Related]

  • 5. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Brooks MM, Chaitman BR, Nesto RW, Hardison RM, Feit F, Gersh BJ, Krone RJ, Sako EY, Rogers WJ, Garber AJ, King SB, Davidson CJ, Ikeno F, Frye RL, BARI 2D Study Group.
    Circulation; 2012 Oct 23; 126(17):2115-24. PubMed ID: 23008442
    [Abstract] [Full Text] [Related]

  • 6. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
    Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V.
    J Am Coll Cardiol; 2013 Apr 16; 61(15):1607-15. PubMed ID: 23500281
    [Abstract] [Full Text] [Related]

  • 7. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC, Hueb W, Garzillo CL, Lima EG, Hueb AC, Ramires JA, Kalil Filho R.
    J Thorac Cardiovasc Surg; 2013 Nov 16; 146(5):1105-12. PubMed ID: 22944095
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH.
    Coron Artery Dis; 2010 Nov 16; 21(7):391-6. PubMed ID: 20634693
    [Abstract] [Full Text] [Related]

  • 9. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL, Schaff HV.
    Coron Artery Dis; 2010 Nov 16; 21(7):402-6. PubMed ID: 20706113
    [Abstract] [Full Text] [Related]

  • 10. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF, Boden WE.
    Curr Atheroscler Rep; 2010 Nov 16; 12(6):423-31. PubMed ID: 20845088
    [Abstract] [Full Text] [Related]

  • 11. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ, Boden WE, Brooks MM, Vlachos H, Chaitman BR, Frye R, Bittner V, Hartigan PM, Dagenais GR.
    Atherosclerosis; 2018 Oct 16; 277():186-194. PubMed ID: 29861270
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL, BARI 2D Investigators.
    Circulation; 2013 Aug 20; 128(8):785-94. PubMed ID: 23857320
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.
    Kamalesh M, Sharp TG, Tang XC, Shunk K, Ward HB, Walsh J, King S, Colling C, Moritz T, Stroupe K, Reda D, VA CARDS Investigators.
    J Am Coll Cardiol; 2013 Feb 26; 61(8):808-16. PubMed ID: 23428214
    [Abstract] [Full Text] [Related]

  • 14. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE.
    Coron Artery Dis; 2010 May 26; 21(3):189-98. PubMed ID: 20308880
    [Abstract] [Full Text] [Related]

  • 15. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L, Kip KE, Alderman E, Lu J, Bates ER, Srinivas V, Bach RG, Mighton LD, Feit F, King S, Frye RL, BARI 2D Study Group.
    Am J Cardiol; 2009 Mar 01; 103(5):632-8. PubMed ID: 19231325
    [Abstract] [Full Text] [Related]

  • 16. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ, Novak E, Brown DL.
    Coron Artery Dis; 2017 Jun 01; 28(4):301-306. PubMed ID: 28346285
    [Abstract] [Full Text] [Related]

  • 17. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
    Kim LJ, King SB, Kent K, Brooks MM, Kip KE, Abbott JD, Jacobs AK, Rihal C, Hueb WA, Alderman E, Sing IR, Attubato MJ, Feit F, BARI 2D (Bypass Angioplasty Revascularization Investigation Type 2 Diabetes) Study Group.
    JACC Cardiovasc Interv; 2009 May 01; 2(5):384-92. PubMed ID: 19463459
    [Abstract] [Full Text] [Related]

  • 18. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY, Xu H, Shi DZ, Wen C, Liu BY.
    J Ethnopharmacol; 2012 Jun 01; 141(2):578-83. PubMed ID: 21924336
    [Abstract] [Full Text] [Related]

  • 19. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE.
    Rev Cardiovasc Med; 2009 Jun 01; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [Abstract] [Full Text] [Related]

  • 20. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A, Phillips HR, Shaw LK, Starr AZ, Fiuzat M, O'Connor CM, Sastry A, Shaw LJ, Borges-Neto S.
    JACC Cardiovasc Imaging; 2012 Jul 01; 5(7):715-24. PubMed ID: 22789940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.